Group Comparisons Based on severity, among the total number of students in this study, 14.1% were assigned to the control group ( n = 25), 14.7% were assigned to the S group ( n = 26), 54.8% were assigned to the SA group ( n = 97), and 16.4% were assigned to the SAD group ( n = 29)
Call us today at 941-254-6767 to schedule a consultation, or schedule an appointment online.
Developed to help people with type 2 diabetes control their blood sugar levels, these GLP-1 medications have generated billions of dollars in revenue for their ability to slow the pace of digestion and reduce appetite, helping millions worldwide lose weight
Zhao L, Rao X, Zheng R, Kong R, Li S
The agency's Adverse Event Reporting System (FAERS) continuously collects reports of adverse events, including cancer diagnoses, among patients using these medications, though such reports do not establish causation
The synergy between clinical trials-backed injectable medications and everyday life changes can lead to successful management of such challenging health conditions.